Pharmacovigilance-2015 Report

We would like to thank all of our wonderful speakers, conference attendees, students, associations and guests for making Pharmacovigilance-2015 a wonderful event!

OMICS International hosted  Pharmacovigilance-2015 which was scheduled during August 10-12, 2015 at Crowne Plaza London Heathrow, UK with the theme  Reviving Strategies for Safer Therapeutics in Healthcare System”

The conference had several workshops, multiple sessions, Keynote presentations, panel discussions and Poster sessions. We received active participation from various leaders from the fields of Pharmacovigilance and Health Care Business, Professors, Pharmacovigilance Companies, Researchers, students and Research Professionals, who made this event a Grand Success.

Various sessions were carried out with multiple presentations from speakers all around the world. Major Sessions to be discussed were:

• Concept of Pharmacovigilance and its Significance and Scope
• Pre-Clinical and Clinical Trials
• Clinical Trials on Drugs used in Various Disorders, Pharmacotherapy and Pharmacotherapeutics
• Adverse Drug Reactions
• Pharmacokinetics and Pharmacodynamics
• Pharmacovigilance and Risk Management
• Good Pharmacovigilance Practice and Pharmacoepidemiology
• Clinical Pharmacology and Biopharmaceutics
• Case Report in Clinical Trials
• Pharmacy Practices and its Challenges

The conference was initiated with a series of lectures delivered by both Honorable Guests and members of the Keynote forum. The list includes:

• Greg Koski, Alliance for Clinical Research Excellence and Safety, USA
• Angela van der Salm, DADA Consultancy B.V., Netherlands
• Peter Lannon, Lanpharm Consulting T/A Lanpharm Services, UK
• Kieran O’Donnell, TMC Pharma Services, UK
• Alistair Coates, Oviya MedSafe, UK

Series of workshops includes expert presentation by Dr. Greg Koski, Co-founder and President of Alliance for Clinical Research Excellence and Safety, USA, on “Tomorrow, today: Systems approaches to enhance pharmacovigilance and risk management”, Angela van der Salm, Director Pharmacovigilance / Managing partner at DADA Consultancy B.V., Netherlands on “The EU-RMP-Planning risk management in a feasible  fashion”, Giovanni Furlan, EU QPPV from Helsinn Birex Pharmaceuticals, Ireland on “Ineffi ciencies in pharmacovigilance: What we can do now and what could be done in the future”, Subodh Bhardwaj, Vice President  of Arable Corporation, USA, on “Vaccine vigilance: Towards strengthening pharmacovigilance”, Pramod Wable, QA Manager from Daiichi Sankyo Development Ltd, UK, on “Lean, six sigma and ISO and their applications in clinical trials/research”, Doaa A Ghareeb, Associate professor from Alexandria University, Egypt, on “Potential molecular mechanism of Berberise vulgaris extract, berberine and berberine chitosan nanoparticles in Alzheimer treatment”

OMICS International offers its heartfelt appreciation to the Organizing Committee Members, namely Angela van der Salm, Peter Lannon, Subodh Bhardwaj who supported us throughout the event. Also, it would be incomplete without thanking all our expert presenters from all around the world which includes various outside experts, company representatives and other eminent personalities who supported the conference by facilitating the discussion forums.

With the grand success of Pharmacovigilance-2015, OMICS International is proud to announce the “5th International Conference & Exhibition on Pharmacovigilance & Clinical Trials" to be held during September 19-21, 2016 at Vienna, Austria.

For More details visit: http://pharmacovigilance.pharmaceuticalconferences.com/